(R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione

Term ID

CHEBI:156218

Synonyms

(7R)-7-[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidine-1-carbonyl]-1,3-diazepane-2,4-dione
(7R)-7-[[4-(1,6-dihydro-6-oxo-4-pyrimidinyl)-1-piperidinyl]carbonyl]dihydro-1H-1,3-diazepine-2,4(3H,5H)-dione
(7R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione
(R)-7-(4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidine-1-carbonyl)-1,3-diazepane-2,4-dione
DB-23
DB23

Definition

Piperidine carrying a 6-oxo-1,6-dihydropyrimidin-4-yl group at C-4 and a [(4R)-2,7-dioxo-1,3-diazepan-4-yl]carbonyl substituent on N-1. One of a series of mucosal-associated invariant T (MAIT) cell agonists.

References

PMID:32341160

Ontology

ChEBI ( EBI )

Relationships

is a type of: piperidines pyrimidone

piperidines pyrimidone Show first 5 Terms

Phenotype

Phenotype resulting from (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione

Phenotype where environments contain (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione

Phenotype modified by environments containing (R)-7-{[4-(6-oxo-1,6-dihydropyrimidin-4-yl)piperidin-1-yl]carbonyl}-1,3-diazepane-2,4-dione

Human Disease Model